Conference Coverage

Major message: Most heart failure is preventable


 

EXPERT ANALYSIS FROM THE ANNUAL CARDIOVASCULAR CONFERENCE AT SNOWMASS

ACE inhibitors and ARBs

The ACC/AHA heart failure guidelines give a Class I recommendation to the routine use of ACE inhibitors or ARBs in patients at high risk for developing heart failure because of a history of diabetes, hypertension with associated cardiovascular risk factors, or any form of atherosclerotic vascular disease.

Lifestyle modification

Heavy drinking is known to raise the risk of heart failure. However, moderate alcohol consumption may be protective. In a classic prospective cohort study, individuals who reported consuming 1.5-4 drinks per day in the previous month had a 47% reduction in subsequent new-onset heart failure, compared with teetotalers in a multivariate analysis adjusted for conventional cardiovascular risk factors. Those who drank less than 1.5 drinks per day had a 21% reduction in heart failure risk, compared with the nondrinkers (JAMA. 2001 Apr 18;285[15]:1971-7).

In the prospective observational Physicians’ Health Study of nearly 21,000 men, adherence to six modifiable healthy lifestyle factors was associated with an incremental stepwise reduction in lifetime risk of developing heart failure. The six lifestyle factors – a forerunner of the AHA’s Life’s Simple 7 – were maintaining a normal body weight, stopping smoking, getting exercise, drinking alcohol in moderation, consuming breakfast cereals, and eating fruits and vegetables. Male physicians who shunned all six had a 21.2% lifetime risk of heart failure; those who followed at least four of the healthy lifestyle factors had a 10.1% risk (JAMA 2009 Jul 22;302[4]:394-400).

In a separate analysis from the Physicians’ Health Study, men who engaged in vigorous exercise to the point of breaking a sweat as little as one to three times per month had an 18% lower risk of developing heart failure during follow-up, compared with inactive men (Circulation 2009 Jan 6;119[1]:44-52).

Pages

Recommended Reading

Fight statin phobia with hard facts
MDedge Endocrinology
Canagliflozin falls short for primary CV prevention in T2DM
MDedge Endocrinology
Aspirin blunts early stroke risk from preeclampsia
MDedge Endocrinology
NASH rapidly overtaking hepatitis C as cause of liver cancer
MDedge Endocrinology
NIAID proposes 3-pronged plan for universal influenza vaccine
MDedge Endocrinology
Heart attacks soar in young IBD patients
MDedge Endocrinology
Three regular meals a day is best in T2DM
MDedge Endocrinology
SGLT2 inhibitors cut cardiovascular outcomes regardless of region
MDedge Endocrinology
MDedge Daily News: Avoid warfarin’s polypharmacy perils
MDedge Endocrinology
Statin use is uniformly low in adults with dyslipidemia disorders
MDedge Endocrinology